Global Cervical Cancer Treatment Market Report and Forecast 2024-2032

Global Cervical Cancer Treatment Market Outlook

The global cervical cancer treatment market attained a value of USD 7.24 billion in 2023. The market is expected to grow further at a CAGR of 6.4% during the forecast period of 2024-2032 to attain a value of USD 12.65 billion by 2032, driven by the rising prevalence of the disease across the globe.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Cervical Cancer Treatment Market: Introduction

Cervical cancer is the type of cancer that starts in the cervix, which is a part that connects the vagina to the uterus. Women over the age of thirty are more vulnerable to the risk of cervical cancer. Cervical cancer mostly happens to women who are sexually active and is caused due to the transmission of a virus called human papillomavirus (HPV) during sexual activities. While most of the women the virus at some point of their lives, only some of those women get cervical cancer. The virus does not show any significant symptoms, so the chances are that women who have it, would not even know. It only becomes a problem when it stay for a longer period and leads to the development of cancer cells in the cervical. Other than this virus, other factors that lead to higher chances of cervical cancer include HIV and tobacco consumption.

The main diagnostic methods for the disease include HPV vaccine and screening tests and the early the tests are done, the higher is the chance of survival. Although the cancer is easily treatable, it needs to be detected as early as possible for effective treatment, that ensures that the patient can lead a healthy life after the treatment. The possibility of recurrence is also less if the treatment is done well. The most effective way of preventing the possibility of having cervical cancer is to get HPV vaccine to minimise or eradicate the chances of cervical, vulvar, and vaginal cancers. These vaccinations can be taken in different age groups and can be started from as early as 9 years. If not as early as 9 years, this vaccine can also be taken in the older age with doctor’s advice in different shots. The chances of prevention, however, decrease as the person ages without the vaccination. Moreover, the vaccine can also reduce the chances of tumours in the future and not treat any existing tumour in the body. For this reason, it is important to get regular screening done in order to detect any existing cancer. 

Common symptoms of cervical cancer include  the following:

• Watery/ Bloody Vaginal Discharge- This discharge could be thick and have a foul smell.

• Vaginal Bleeding – During or after intercourse, during menstruation cycles, or even after menopause.

• Menstruation Cycles- It could be painful and might last longer, the flow might be heavier.

In case the cancer spreads to other tissues or organs, the symptoms can get worse. The severe symptoms would include painful urination, presence of blood in urine, pain in rectum or bleeding in rectum. Other symptoms can be fatigue, loss of appetite, severe weight loss, perennial backache, swelling in the legs, pain in pelvic or abdominal region, among others.

Diagnostic Methods in the Cervical Cancer Treatment Market

These are two major diagnostic methods in the market currently:

The Pap Test/ Pap Smear- This test helps in identifying precancers or cancer cells that start developing in the cervical. In the test, cells are collected from the cervix to detect cancer in the cervix. The early detection of the cancer helps in getting early treatment. It is recommended for women to get these tests done every three years between the age group of 21-65.

HPV Test- This test detects the presence of HPV virus in the cervix and can help reduce the chances of getting cervical cancer if the virus is killed at the initial stage only.

Cervical Cancer Treatment Market Segmentations

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The cervical cancer treatment market can be categorised into segments like stage, tests, cell type, product type, treatment channels, and regions.

Market Breakup by Stage

• Stage 0

• Stage 1

• Stage 2

• Stage 3

• Stage 4

Market Breakup by Tests

• Pap Smear Test Procedure

• Colposcopy Procedure

• ECC Procedure

• Others

Market Breakup by Cell Type

• Adenocarcinoma

• Squamous Cell Carcinoma

• Adenosquamous Carcinoma

Market Breakup by Product Type

• Gardasil/Gardasil 9

• Cervarix

• Avastin

• Keytruda

• Generics

• Others

Market Breakup by Treatment Channel

• Public

• Private

Market Breakup by Region

• North America
  • United States of America
  • Canada
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
• Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Cervical Cancer Treatment Market- Epidemiology

Cervical cancer is among the leading types of cancer amongst women. In 2020, the number of cervical cancer cases was close to 604000 and the death rate reached 342000. According to the estimates by American Cancer Society, nearly 13,960 more cases of cervical cancer will be diagnosed in 2024 and the death toll will reach close to 4,310 by 2024. Earlier, the number of deaths due to cervical cancer was extremely high in the United States but the numbers have now reduced significantly reduced due to the rising use of available tests like Pap test and HPV test due to the rising awareness. 

The prevalence of cervical cancer is highest amongst older women, especially in the age group of 35-45. The possibility of having cervical cancer increases with age, about 20% of women are diagnosed with cancer when they are over the age of 65. Women under the age of 20 are less vulnerable to the disease.

Cervical Cancer Treatment Market- Therapeutic Landscape

Cervical cancer can be efficiently treated, if diagnosed early. The current treatment methods for cervical cancer include the following methods:

Radiation Therapy- This therapy uses beams or radiations to eliminate the cancer cells, The two therapies included in the market are External beam radiation therapy (EBRT) and Brachytherapy.

Chemotherapy- This method uses drugs to attack the tumour cells. These drugs are either given in injection or taken orally. The treatment is done in various cycles and the dose, and the length of treatment depends upon the grade and location of the cancer.

Surgery- There are various surgeries available for the treatment of cervical cancer. These surgeries include laser surgery, cryosurgery, cone biopsy, simple hysterectomy, radical hysterectomy with pelvic lymph node dissection, trachelectomy, and pelvic exenteration.

Targeted Therapy- This therapy attacks the cancer cells without affecting the healthy cells. The drugs target the proteins that control the spread of the cells.

Immunotherapy- This therapy comprises the use of drugs to boost the immunity cells to fight the cancer cells. 

Clinical Trials  in the Cervical Cancer Treatment Market

There are numerous studies which are currently under trials, some of these ongoing trials are as follows:

• A Phase II Evaluation of Nivolumab, a Fully Human Antibody Against PD-1, in the Treatment of Persistent or Recurrent Cervical Cancer (Last updated in January 2023) - This trial is currently under the phase II of studying the effects of using a drug called Nivolumab in patients with persistent, metastatic, and/ or recurrent cervical cancer. This study is sponsored by National Cancer Institute (NCI), in collaboration with the NRG Oncology. Monoclonal antibodies like Nivolumab can help restrict or completely block the growth of the tumour cells. The study is also studying the possibility of toxic effects that Nivolumab can exhibit.

• Study of Combination Radiation Therapy and Cisplatin, with or without Triapine - This study is currently under the third phase of clinical trial. Triapine might be effective in restricting and preventing the development of cancer cells by blocking the enzymes that help in cell growth. The study is aimed at directing the effectiveness of radiation therapy and cisplatin with the use of triapine in the treatment of cervical cancer.

Key Players in the Global Cervical Cancer Treatment Market

• F. Hoffmann-LA Roche AG

• Merck & Co., Inc.

• GlaxoSmithKline Plc.

• Allergan Inc. (AbbVie, Inc.)

• Biocon Limited

• Pfizer Inc.

• Eli Lilly and Company

• Hologic Inc.

• Qiagen N.V.

• Quest Diagnostics Inc.

• Dickinson and Co.

• Bio-Rad Laboratories Inc.

Key Highlights of the Report

Cervical Cancer Treatment Market Report Snapshots

Cervical Cancer Treatment Market Size

Cervical Cancer Treatment Companies